SCHEMBL9325697

SCHEMBL9325697

O=C(O)Cc1ccc2c(c1)CCN2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
AKR1B1 P15121 2/20 0.47
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
RGS12 O14924 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
APEX1 P27695 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5778832 0.90 KDM4E (0.60) DRD2DRD4KDM4EMAPTAKR1B1
SCHEMBL31285975 0.90 KDM4E (0.60) DRD2DRD4KDM4EMAPTAKR1B1
SCHEMBL9328756 0.87 KDM4E (0.45) DRD2DRD4KDM4EMAPTAKR1B1
SCHEMBL29642979 0.85 DRD2 (0.50) DRD2DRD4KDM4EMAPTALDH1A1
SCHEMBL7260939 0.84 DRD2 (0.49) DRD2DRD4KDM4EMAPTRXRA
SCHEMBL6274911 0.81 ALDH1A1 (0.47) DRD2DRD4KDM4EMAPTHPGD
SCHEMBL28404333 0.81 KDM4E (0.49) KDM4EMAPTAKR1B1HPGDHSD17B10
SCHEMBL12736108 0.79 DRD2 (0.58) DRD2DRD4KDM4EMAPTHSD17B10
Phenylacetic Acid SCHEMBL27898390 0.79 AKR1B1 (0.55) DRD2DRD4AKR1B1ALDH1A1RXRA
SCHEMBL12324805 0.78 DRD2 (0.57) DRD2DRD4KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104395290-A Novel adamantyl derivatives as cannabinoid receptor 2 agonists HOFFMANN LA ROCHE 2015-03-04 CN disclosed
US-5288749-A Treating central nervous system or cardiovascular disorders ABBOTT LABORATORIES (US) 1994-02-22 US disclosed
WO-1993012754-A2 TERTIARY AND SECONDARY AMINES AS ALPHA-2 ANTAGONISTS AND SEROTONIN UPTAKE INHIBITORS ABBOTT LABORATORIES (US) 1993-07-08 WO disclosed